# Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

> **NCT02416674** · EARLY_PHASE1 · UNKNOWN · sponsor: **Brigham and Women's Hospital** · enrollment: 10 (estimated)

## Conditions studied

- Abdominal Wall Defect

## Interventions

- **PROCEDURE:** abdominal wall transplantation
- **DRUG:** Immunosuppressive Agents

## Key facts

- **NCT ID:** NCT02416674
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-03-01
- **Primary completion:** 2025-02
- **Final completion:** 2025-02
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2023-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02416674

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02416674, "Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02416674. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*